Results
29
Companies with a Future performance score of at least 3, ordered by Future performance score.
29 companies
Camurus
Market Cap: SEK 29.6b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 505.00
7D
-4.4%
1Y
-5.7%
Bonesupport Holding
Market Cap: SEK 16.8b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 255.00
7D
-9.3%
1Y
3.2%
Xbrane Biopharma
Market Cap: SEK 330.0m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 0.22
7D
-14.6%
1Y
-20.2%
Diamyd Medical
Market Cap: SEK 917.3m
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 8.78
7D
-4.9%
1Y
-22.3%
Guard Therapeutics International
Market Cap: SEK 357.0m
A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
GUARD
SEK 17.70
7D
15.7%
1Y
-45.7%
Ascelia Pharma
Market Cap: SEK 498.3m
A biotech company, focuses on orphan oncology treatments in Sweden.
ACE
SEK 4.30
7D
0.9%
1Y
-54.5%
Lipigon Pharmaceuticals
Market Cap: SEK 14.1m
Develops drugs for lipid related diseases in Sweden.
LPGO
SEK 0.095
7D
-0.6%
1Y
-68.3%
Corline Biomedical
Market Cap: SEK 240.0m
Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.
CLBIO
SEK 9.80
7D
-4.9%
1Y
-12.5%
Klaria Pharma Holding AB (publ.)
Market Cap: SEK 62.2m
A pharmaceutical company develops and commercializes medication for migraine and cancer related pain, as well as opioid overdose and anaphylactic shock.
KLAR
SEK 0.43
7D
-51.9%
1Y
-53.7%
Devyser Diagnostics
Market Cap: SEK 1.7b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 102.40
7D
-4.3%
1Y
2.4%
Active Biotech
Market Cap: SEK 340.8m
A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.
ACTI
SEK 0.28
7D
62.9%
1Y
-49.6%
Egetis Therapeutics
Market Cap: SEK 1.1b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 3.12
7D
-3.0%
1Y
-62.5%
SynAct Pharma
Market Cap: SEK 743.0m
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 15.16
7D
-15.4%
1Y
119.2%
BioInvent International
Market Cap: SEK 2.4b
A clinical-stage company, discovers, and develops novel immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.
BINV
SEK 37.00
7D
14.2%
1Y
16.7%
Mendus
Market Cap: SEK 262.0m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 5.03
7D
1.1%
1Y
-44.8%
Hansa Biopharma
Market Cap: SEK 1.6b
A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.
HNSA
SEK 23.30
7D
-5.0%
1Y
-45.4%
AlzeCure Pharma
Market Cap: SEK 258.7m
Operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.
ALZCUR
SEK 2.93
7D
17.7%
1Y
49.5%
Moberg Pharma
Market Cap: SEK 435.6m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 9.33
7D
5.9%
1Y
-61.6%
Initiator Pharma
Market Cap: SEK 212.8m
A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.
INIT
SEK 3.79
7D
5.3%
1Y
-57.9%
AddLife
Market Cap: SEK 22.3b
Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 183.40
7D
-0.5%
1Y
64.5%
Genovis AB (publ.)
Market Cap: SEK 1.8b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 26.95
7D
5.1%
1Y
-23.1%
Magle Chemoswed Holding
Market Cap: SEK 590.9m
Operates as a contract development and manufacturing organization that serves pharmaceutical and medical device industry on a contract basis in Sweden.
MAGLE
SEK 28.80
7D
9.9%
1Y
-11.1%
Biotage
Market Cap: SEK 11.3b
Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.
BIOT
SEK 141.70
7D
-0.2%
1Y
-17.8%
Swedencare
Market Cap: SEK 6.4b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 40.30
7D
-1.8%
1Y
-31.7%
Elicera Therapeutics
Market Cap: SEK 312.1m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 6.43
7D
25.1%
1Y
581.1%
FluoGuide
Market Cap: SEK 570.7m
A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.
FLUO
SEK 41.90
7D
-3.7%
1Y
-11.8%
Vitrolife
Market Cap: SEK 20.8b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 153.70
7D
-2.4%
1Y
-12.3%
BioGaia
Market Cap: SEK 10.6b
A healthcare company, provides probiotic products worldwide.
BIOG B
SEK 103.70
7D
-0.3%
1Y
-17.3%
Swedish Orphan Biovitrum
Market Cap: SEK 100.8b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 293.60
7D
-5.3%
1Y
7.6%